The potential value of rapid, cloud-enabled onsite testing for the diagnosis of rheumatoid arthritis in the United States

Abstract

Data on the impact of rapid, cloud-enabled, onsite testing on patient health, care delivery, and clinical decision-making is scarce. More robust real-world data would confirm the validity of our model. Rapid, cloud-enabled, onsite testing has the potential to generate significant value to payers.